Muscle News and Research

RSS

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Surveying patients with traumatic brain injuries, a group of Los Angeles Biomedical Research Institute researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.

3 Oct 2014

Energy drinks increase frequency of insomnia, nervousness in athletes

A study analysing the positive and negative effects of energy drinks on athletes has seen that, although in principle their sports performance was seen to improve by between 3% and 7%, there was also an increase in the frequency of insomnia, nervousness and the level of stimulation in the hours following competition.

3 Oct 2014

Researchers reveal that drug-food interactions may endanger mountaineer’s health

University of the Basque Country researchers have studied the nutritional and health situations existing at high altitudes as well as the routinely used nutritional ergogenic and pharmacological aids. According to their study, the possible interactions between drugs and food and nutrients taken may endanger the mountaineer’s health if all this is not conducted under strict control.

3 Oct 2014

Montmorency cherry concentrate helps reduce effects of gout

Drinking Montmorency concentrate significantly helps to reduce the effects of the painful condition gout, according to new research.

3 Oct 2014

Longer looks: Dying at home; losing religion; Obamacare 2.0

He was still her handsome father, the song-and-dance man of her childhood, with a full head of wavy hair and blue eyes that lit up when he talked. But he was gaunt now, warped like a weathered plank, perhaps by late effects of an old stroke, certainly by muscle atrophy and bad circulation in his legs. Now she was determined to fulfill her father's dearest wish, the wish so common among frail, elderly people: to die at home. But it seemed as if all the forces of the health care system were against her - hospitals, nursing homes, home health agencies, insurance companies, and the shifting crosscurrents of public health care spending (Nina Bernstein, 9/25).

3 Oct 2014

MS patients can benefit from strength training and fitness exercises

A study developed at the Miguel Hernández University of Elche (Spain) has preliminarily concluded that people with multiple sclerosis may reduce perceived fatigue and increase mobility through a series of combined strength training and fitness exercises.

1 Oct 2014

Family physician answers questions related to Ebola virus

According to the Centers for Disease Control, the outbreak of Ebola in four West African countries is one of the largest outbreaks of the disease in history.

1 Oct 2014

Study shows healthy fat in olive oil may revive a failing heart

Oleate, a common dietary fat found in olive oil, restored proper metabolism of fuel in heart cells in an animal model of heart failure.

1 Oct 2014

Pitt researchers awarded $11.8 million NIH grant to explore genetic roots of cleft lip, palate

Researchers at the University of Pittsburgh School of Dental Medicine have been awarded a $11.8 million, five-year grant from the National Institute of Dental and Craniofacial Research, part of the National Institutes of Health, to continue their exploration of the genetic roots of cleft lip and cleft palate and to expand the effort to include populations in Colombia, Nigeria, the Philippines and Pennsylvania.

30 Sep 2014

Synapse Biomedical completes enrollment in post-approval study of NeuRx DPS for ALS patients

Synapse Biomedical Inc. announced today it has completed the enrollment of the post-approval study of its NeuRx DPS System for ALS patients.

30 Sep 2014

CytRx begins aldoxorubicin Phase 2b clinical trial in patients with extensive-stage SCLC

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of a global Phase 2b clinical trial evaluating aldoxorubicin compared to topotecan in subjects with extensive-stage small cell lung cancer (SCLC) who have relapsed or were refractory to prior chemotherapy.

30 Sep 2014

TSRI study points way to potential therapies for hereditary spastic paraplegia

Scientists at The Scripps Research Institute have discovered that a gene mutation linked to hereditary spastic paraplegia, a disabling neurological disorder, interferes with the normal breakdown of triglyceride fat molecules in the brain. The TSRI researchers found large droplets of triglycerides within the neurons of mice modeling the disease.

30 Sep 2014

Cedars-Sinai experts to present free conference on dystonia for patients, families and caregivers

A multidisciplinary team of experts affiliated with the Cedars-Sinai Movement Disorders Program will present a free conference for patients, families and caregivers on treatment options for dystonia, which causes painful and potentially crippling muscle contractions.

30 Sep 2014

Researchers explain how molecular structure of the heart muscle changes in heart failure

In a new study published in Proceedings of the National Academy of Sciences USA, researchers at the University of Alberta's Faculty of Medicine & Dentistry have explained how the function of a key protein in the heart changes in heart failure.

30 Sep 2014

Increasing prevalence of obstructive sleep apnea threatens public health and safety

Public health and safety are threatened by the increasing prevalence of obstructive sleep apnea, which now afflicts at least 25 million adults in the U.S., according to the National Healthy Sleep Awareness Project. Several new studies highlight the destructive nature of obstructive sleep apnea, a chronic disease that increases the risk of high blood pressure, heart disease, Type 2 diabetes, stroke and depression.

29 Sep 2014

HerKare opens new location in Mansfield, Texas

HerKare opens a new location today in Mansfield, Texas. This marks HerKare's third center in Dallas-Fort Worth. HerKare recently expanded to Houston area and continues to accelerate their growth plans, making the treatment of hormonal imbalance in women more convenient.

29 Sep 2014

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.

29 Sep 2014

OSU engineers develop simple device to improve hand function after surgery

Engineers at Oregon State University have developed and successfully demonstrated the value of a simple pulley mechanism to improve hand function after surgery.

29 Sep 2014

FDA grants multiple Orphan Drug Designations for CytRx's aldoxorubicin

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.

29 Sep 2014

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

A new drug, anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia and cachexia, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Muscle News and Research

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Energy drinks increase frequency of insomnia, nervousness in athletes

Researchers reveal that drug-food interactions may endanger mountaineer’s health

Montmorency cherry concentrate helps reduce effects of gout

Longer looks: Dying at home; losing religion; Obamacare 2.0

MS patients can benefit from strength training and fitness exercises

Family physician answers questions related to Ebola virus

Study shows healthy fat in olive oil may revive a failing heart

Pitt researchers awarded $11.8 million NIH grant to explore genetic roots of cleft lip, palate

Synapse Biomedical completes enrollment in post-approval study of NeuRx DPS for ALS patients

CytRx begins aldoxorubicin Phase 2b clinical trial in patients with extensive-stage SCLC

TSRI study points way to potential therapies for hereditary spastic paraplegia

Cedars-Sinai experts to present free conference on dystonia for patients, families and caregivers

Researchers explain how molecular structure of the heart muscle changes in heart failure

Increasing prevalence of obstructive sleep apnea threatens public health and safety

HerKare opens new location in Mansfield, Texas

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

OSU engineers develop simple device to improve hand function after surgery

FDA grants multiple Orphan Drug Designations for CytRx's aldoxorubicin

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News